Vaginal Drug Delivery Beyond Gynecology: Let’s Think Outside “The Box”
Pun totally intended. Absolutely, 100% But go with me here. When you hear “vaginal drug delivery,” I’m guessing you think “reproductive medicine.” But there is increasing evidence that the vaginal route offers unique anatomical, physiological, and pharmacokinetic advantages that can be leveraged for systemic treatment of non-gynecological conditions. What’s that, you ask? Could women have …
CLCC attending WHX Dubai
☀️ Excited to be heading to WHX Dubai 2026 to next week — and especially looking forward to showcasing our Callavid® drug delivery platform on stage as part of the Xcelerate Pitch Competition, within the dedicated Femtech & Women’s Health track. As the largest healthcare event in the region, WHX brings together a comprehensive mix …
200 Trailblazing WH Leaders List (3rd year running)
Our co-founders Lara and Thang have been named in the annual ‘200 Trailblazing Leaders in Women’s Health and FemTech’ for the third year running. It’s a real who’s who of the influential leaders working to improve the access and quality of healthcare for women worldwide. We’re delighted at the recognition for Lara & Thang and of …
Ignite Pitch Competition Winner at JPM 2026
We’re delighted to share that our co-founder Lara was crowned the winner of the 🔥 Ignite Fire Pitch Competition, held during J.P. Morgan Week in San Francisco 🇺🇸 Ignite is a U.S. non-profit with a powerful mission: increasing the number of women leading and innovating the future of healthcare. The Ignite Fire Pitch represents the …
NIHR visit to CLCC labs
We were delighted to host Alex Zabala Findlay, our NIHR (National Institute for Health and Care Research) Programme Manager, for a highly productive visit to our labs. 🔬 As his first visit to our facilities, it was a great opportunity to showcase our bespoke equipment and laboratory capabilities, walk through the R&D challenges we’ve successfully …
Dr Annalisa Jenkins appointed an OBE
✨ Big congratulations to our board advisor Prof/Dr Annalisa Jenkins OBE on being recognised in the King’s New Year Honour’s List! Over more than 25 years, Annalisa has been an outstanding leader in the life sciences– building and guiding teams that have successfully taken programmes from early scientific discovery through clinical development, regulatory approval, and …
CLCC at JPM Healthcare Conference
Calla Lily Clinical Care is pleased to be heading back to San Francisco for the J.P. Morgan Healthcare Conference 🇺🇲 From January 12–15, we’ll be on the ground reconnecting with partners, meeting new collaborators, and sharing the continued progress of our Callavid® vaginal drug delivery platform. It’s always a valuable moment in the calendar to …
Year End Reflection
As we wrap up the year, Lara and I are feeling so grateful for this Calla Lily Clinical Care team and everything we’re building together. This photo was taken after our year-end festivities involving axe throwing (!) a well-earned chance to step away from the day-to-day and enjoy each other’s company (and a bit of friendly …
Attending the Jefferies Healthcare Conference
We’re pleased to share that our co-founders Dr Lara Zibners and Thang Vo-Ta will be attending the Jefferies Healthcare Conference from 17–20 November 2025. We’ll be ready to connect, collaborate, and showcase our Callavid® vaginal drug delivery innovation. This is an exciting opportunity to discuss new trends, potential collaborations, and meet with valued partners and …
ISO9001:2015… 3 years running
👏 CLCC is proud to share that we’ve successfully completed our ISO 9001 audit with *zero* major or minor non-conformities for the *third* year in a row. Quality has always been and will always be one of the core pillars of our company, and this result is a testament to the commitment, rigour, and consistency …